A groundbreaking shift in Canadian drug policy has happened, as the regulators permit the availability of psilocybin hallucinogens for therapeutic applications. Until now, these substances were severely restricted, but a increasing body of research suggests they may offer aid for mental health issues like depression. The new policy represents a maj